Shimano CUES adds a special shiny silver edition, perfect for cyclists hoping for a more classy look to their next affordable ...
BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...
Right on cue, another diagnostics-focused startup has made the transition to a public company. The latest to join the droves of medtechs flooding the stock market is Cue Health, which has so far found ...
Plaintiffs recently filed a class-action lawsuit against General Motors for faulty Cadillac CUE infotainment screens. Cadillac owners claim there are physical issues with the system, such as ...
Two years after its cartridge-based diagnostic became the first COVID-19 test given emergency use authorization by the FDA for non-prescription, at-home use, Cue Health has now scored the agency’s ...
In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...
Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago. These figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback